Accumulating evidence has shown that different tumor characteristics were identified in patients with the BRCA1 mutation – less so in patients with the BRCA2 mutation ‐ in comparison to patients without the mutation 25, 26, 27, 28, 29, 30. Here, BRCA2 is linked to neoplasm.